Corbus Pharmaceuticals Holdings (CRBP) Preferred Stock Liabilities (2013)

Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Preferred Stock Liabilities of $1.1 million in Q4 2013.

Corbus Pharmaceuticals Holdings (CRBP) Preferred Stock Liabilities (2013) Analysis & Trends

Corbus Pharmaceuticals Holdings' Preferred Stock Liabilities history runs 1 years deep, the most recent figure standing at $1.1 million for Q4 2013.

In Q4 2013, Preferred Stock Liabilities changed N/A year-over-year to $1.1 million; the TTM figure through Dec 2013 stood at $1.1 million (changed N/A YoY), while the FY2013 annual figure was $1.1 million, changed N/A from the prior year.
Preferred Stock Liabilities was $1.1 million for Q4 2013 at Corbus Pharmaceuticals Holdings.
In the past five years, Preferred Stock Liabilities ranged from a high of $1.1 million in Q4 2013 to a low of $1.1 million in Q4 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	-
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	Corbus Pharmaceuticals Holdings	133.67 Mn	105.86 Mn	-	-

Download Data

Date	Value
Dec 31, 2013	1.11 Mn